Startups Reignite Debate Over CRISPR Human Embryo Editing
Manhattan Genomics and Preventive plan to explore gene editing in human embryos using base and prime editing (newer than CRISPR-Cas9). 80%+ of published analyses flag safety concerns including off-target mutations and effects on future generations.